NEW USE OF NICOTINAMIDE MONONUCLETIDE (NMN) AND NICOTINAMIDE RIBOSIDE (NR) Russian patent published in 2024 - IPC A61K31/706 A61K9/48 A61P27/02 A61P29/00

Abstract RU 2822512 C2

FIELD: medicine; pharmaceutics.

SUBSTANCE: group of inventions relates to the use of nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR) for preparing a drug for improving meibomian gland function or for treating or preventing meibomian gland dysfunction.

EFFECT: use of the group of inventions enables the effective treatment of meibomian gland dysfunctions.

22 cl, 5 dwg, 2 tbl, 5 ex

Similar patents RU2822512C2

Title	Year	Author	Number
THERAPEUTIC AGENT FOR MEIBOMIAN GLAND DYSFUNCTION	2014	Miyake Khideki Oda Tomoko Sii Dajsuke	RU2709542C2
NORMALIZATION OF FUNCTIONS OF BIOLOGICAL PATHWAYS FOR PROTECTION AGAINST AND ELIMINATION OF DISORDERS ARISING FROM HUMAN AGING	2016	Huizenga, Joel	RU2768936C2
NICOTINAMIDE FOR TREATING DISLIPIDEMIA	2018	Ammer, Richard	RU2741426C1
AGENT FOR REDUCING BIOLOGICAL AGE	2019	Moskalev Aleksej Aleksandrovich Zakharov Yurij Aleksandrovich	RU2738644C2
THERAPEUTIC OR PROPHYLACTIC AGENTS TO PREVENT MEIBOMIAN GLAND DYSFUNCTION OR BLOCKING OF MEIBOMIAN GLAND	2012	Kido Kadzutaka Nagano Takasi	RU2586289C1
DRUG PREPARATION CONTAINING PRAR AGONIST	2008	Nakamura Josikuni Khanano Ikuko Inoue Dzun	RU2449789C2
OPHTHALMIC COMPOSITION	2012	Millar Tomas Shuett Berkhard	RU2625301C2
METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES	2016	Jain, Sandeep Kompella, Uday, Bhaskar Musunuri, Shankar	RU2691412C2
METHOD OF TREATING BLEPHAROCONJUNCTIVAL FORM OF DRY EYE SYNDROME	2012	Polunina Elizaveta Gennad'Evna Alieva Ajnura Ehtibarovna	RU2510701C1
PHARMACEUTICAL COMPOSITIONS FOR INHIBITING INFLAMMATORY CYTOKINES	2019	Primor, Naftali	RU2816868C2

RU 2 822 512 C2

Authors

Doi, Masao

Nakajima, Takeshi

Machida, Mamiko

Dates

2024-07-08—Published

2020-06-24—Filed